Skip to main content

Pear Therapeutics, Inc.

PEARDelisted May 2, 2023
Industry
Services-Health Services
SEC CIK
0001835567

Pear Therapeutics, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Apr 12, 2023; 53 institutions reported holding it in 13F filings for Q1 2023, worth $20.7M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in Pear Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
40
−8 vs. Q1 2022
Shares held
76.9M
+559.4K (+0.7%) vs. Q1 2022
Total value
$118.4M
−$267.0M (−69.3%) vs. Q1 2022
New holders
11
10 more added
Sold out
19
5 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PEAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 40 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 25 institutionsQ1 2022: 48 institutionsQ2 2022: 40 institutionsQ3 2022: 60 institutionsQ4 2022: 64 institutionsQ1 2023: 53 institutionsQ2 2023: 1 institutionQ3 2023: 1 institutionQ4 2023: 1 institutionQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $118.4M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $464.3MQ1 2022: $385.3MQ2 2022: $118.4MQ3 2022: $168.1MQ4 2022: $96.3MQ1 2023: $20.7MQ2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding PEAR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$0
Q4 20231$0
Q3 20231$0
Q2 20231$0
Q1 202353$20.7M
Q4 202264$96.3M
Q3 202260$168.1M
Q2 202240$118.4M
Q1 202248$385.3M
Q4 202125$464.3M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Pear Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding PEAR in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Temasek Holdings (Private) Ltd26,803,573$41.3M0.23%00.0%Unchanged
5AM Venture Management, LLC18,631,771$28.7M7.10%00.0%Unchanged
SB Global Advisers Ltd12,100,078$18.6M0.88%00.0%Unchanged
Arboretum Ventures, Inc.10,859,050$16.7M18.57%00.0%Unchanged
TB Alternative Assets Ltd.2,071,865$3.19M1.56%00.0%Unchanged
Vanguard Group Inc1,064,709$1.64M0.00%+19,266+1.8%Added
Palantir Technologies Inc.1,000,000$1.54M1.58%00.0%Unchanged
Perceptive Advisors LLC900,548$1.39M0.04%−25,684−2.8%Reduced
Sarissa Capital Management LP500,356$771.0K0.08%00.0%Unchanged
BlackRock Inc.428,766$660.0K0.00%+12,488+3.0%Added
EDBI Pte Ltd427,070$658.0K0.61%00.0%Unchanged
Deutsche Bank AG350,000$539.0K0.00%+350,000New
Geode Capital Management, LLC347,278$534.0K0.00%+62,715+22.0%Added
State Street Corp312,028$481.0K0.00%+233,313+296.4%Added
Millennium Management LLC248,399$383.0K0.00%+211,551+574.1%Added
Mirae Asset Global Investments Co., Ltd.208,505$321.0K0.00%+208,505New
HRT Financial LP201,829$310.0K0.00%+51,104+33.9%Added
JPMorgan Chase & Co91,969$142.0K0.00%+90,569+6,469.2%Added
Ergoteles LLC72,098$111.0K0.00%+72,098New
Renaissance Technologies LLC69,778$107.0K0.00%+69,778New
Northern Trust Corp60,922$94.0K0.00%−973−1.6%Reduced
Two Sigma Investments, LP23,224$36.0K0.00%+23,224New
Charles Schwab Investment Management Inc19,890$31.0K0.00%00.0%Unchanged
Jump Financial, LLC20,335$31.0K0.00%+20,335New
Bank of New York Mellon Corp11,899$18.0K0.00%+481+4.2%Added
Concord Wealth Partners7,000$11.0K0.00%+7,000New
Citigroup Inc6,132$9.00K0.00%+6,082+12,164.0%Added
Roble, Belko & Company, Inc4,502$7.00K0.00%00.0%Unchanged
BerganKDV Wealth Management, LLC4,500$7.00K0.00%00.0%Unchanged
Gleason Group, Inc.4,250$7.00K0.00%00.0%Unchanged
Penserra Capital Management LLC3,379$5.00K0.00%−1,320−28.1%Reduced
Washington Trust Advisors, Inc.3,000$5.00K0.00%00.0%Unchanged
Morgan Stanley2,221$3.00K0.00%−3,420−60.6%Reduced
Riggs Asset Managment Co. Inc.1,000$2.00K0.00%+1,000New
Patriot Financial Group Insurance Agency, LLC500$1.00K0.00%00.0%Unchanged
Royal Bank of Canada483$1.00K0.00%+483New
Advisor Group Holdings, Inc.914$1.00K0.00%+914New
Bank of America Corp8$00.00%−23,345−100.0%Reduced
Wells Fargo & Company231$00.00%+19+9.0%Added
Highbridge Capital Management LLC99$00.00%+99New
Blue Water Life Science Advisors, LLC0$00.00%−194,686−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−123,515−100.0%Sold out
Citadel Advisors LLC0$00.00%−116,701−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−76,870−100.0%Sold out
Alpine Global Management, LLC0$00.00%−55,287−100.0%Sold out
Squarepoint Ops LLC0$00.00%−50,837−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−39,244−100.0%Sold out
Sciencast Management LP0$00.00%−36,621−100.0%Sold out
Jane Street Group, LLC0$00.00%−32,352−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−28,900−100.0%Sold out
Shay Capital LLC0$00.00%−25,000−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−15,620−100.0%Sold out
Diametric Capital, LP0$00.00%−13,203−100.0%Sold out
Magnus Financial Group LLC0$00.00%−11,800−100.0%Sold out
UBS Group AG0$00.00%−3,292−100.0%Sold out
Ovata Capital Management Ltd0$00.00%−2,100−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−728−100.0%Sold out
Sandy Cove Advisors, LLC0$00.00%−100−100.0%Sold out
DuPont Capital Management Corp0$00.00%−2−100.0%Sold out